MedPath

海南卓科制药有限公司

Ownership
-
Established
2017-10-24
Employees
-
Market Cap
-
Website
www.choitec.net

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Fluorouracil Injection

Product Name
氟尿嘧啶注射液
Approval Number
国药准字H20258073
Approval Date
May 6, 2025
NMPA

Sulpiride Tablets

Product Name
舒必利片
Approval Number
国药准字H44020717
Approval Date
Jul 4, 2024
NMPA

Fluorouracil Injection

Product Name
氟尿嘧啶注射液
Approval Number
国药准字H20243475
Approval Date
Apr 11, 2024
NMPA

Amsacrine

Product Name
安吖啶
Approval Number
国药准字H20093386
Approval Date
Dec 5, 2023
NMPA

Mycophenolate Mofetil

Product Name
吗替麦考酚酯
Approval Number
国药准字H20067341
Approval Date
Mar 12, 2021
NMPA

Aztreonam

Product Name
氨曲南
Approval Number
国药准字H20063721
Approval Date
Mar 26, 2020
NMPA

EnoXacin Gluconate

Product Name
葡萄糖酸依诺沙星
Approval Number
国药准字H20054992
Approval Date
Mar 24, 2020
NMPA

Vidarabine Monophosphate

Product Name
单磷酸阿糖腺苷
Approval Number
国药准字H20057633
Approval Date
Mar 24, 2020
NMPA

Ketorolac Tromethamine

Product Name
酮咯酸氨丁三醇
Approval Number
国药准字H20063725
Approval Date
Mar 6, 2020
NMPA

Meglumine

Product Name
葡甲胺
Approval Number
国药准字H46020240
Approval Date
Mar 6, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.